Voya Investment Management 13F: Cuts ALAB Stake by $47M
Voya Investment Management reduces its stake in Astera Labs by over 43%, according to the latest 13F filing.
Reviewed by automated data checks against the source filing. How we make and check alerts
Voya Investment Management sold 95,324 shares from its stake in Astera Labs, Inc. ($ALAB), a 43.40% decrease, according to a 13F filing with the SEC dated May 12, 2026. It reported 124,304 shares worth $61.46 million at the end of the quarter.
Since the filing, $ALAB is up 19.5% after 1 week, up 79.8% after 1 month and up 39.8% to date (from the $204.42 close on May 12, 2026).
Find the original: Voya Investment Management 13F filings on SEC EDGAR
Key Points
- Voya Investment Management cut its Astera Labs stake by 43.4%, reducing its holdings by 95,324 shares to 124,304 shares as of the latest 13F filing.
- Astera Labs, trading near $494.4, has a market cap of $82.8 billion and a P/E ratio of 330.8, with a 52-week range between $85.85 and $499.48.
- Insiders at Astera Labs, including Bethany Mayer and Jack Lazar, sold shares in June, while analysts maintain varied ratings with price targets ranging from $200 to $460.
Get $ALAB trade alerts by text
We text you when insiders, Congress or big funds trade $ALAB. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Astera Labs, Inc. alert may contain errors. Disclosures
Voya Investment Management has reduced its stake in Astera Labs, Inc. (NasdaqGS: ALAB) by 43.4%, according to its latest 13F filing with the SEC. The firm sold 95,324 shares, bringing its total holdings to 124,304 shares valued at approximately $61.5 million as of the reporting period.
Voya Investment Management vs. the S&P 500
Hypothetical returns from Voya Investment Management's disclosed trades, not real profit or advice. How we model this.
What Changed in Voya Investment Management's Astera Labs Position
Voya Investment Management significantly trimmed its position in Astera Labs, decreasing its holdings from 219,628 shares to 124,304 shares. This reduction of 95,324 shares represents a 43.4% decrease in its investment, reflecting a strategic adjustment in its portfolio.
Other Institutional Activity in Astera Labs
FMR LLC increased its holdings in Astera Labs by 194,944 shares, now holding 25,529,885 shares valued at about $2.8 billion, marking a modest 0.8% increase. In contrast, BlackRock, Inc. reduced its position by 1,519,089 shares, representing an 11.7% decrease, leaving it with 11,449,769 shares worth approximately $1.25 billion. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, acquiring 7,309,778 and 6,340,732 shares, respectively. Atreides Management, LP boosted its stake by 1,754,593 shares, a 108.9% increase, to a total of 3,365,787 shares valued at $368.9 million.
Astera Labs, Inc. Stock Up 64.6%
As of Wednesday, shares of Astera Labs were trading around $494.4. The company boasts a market capitalization of $82.8 billion and a high P/E ratio of 330.8, indicating strong investor expectations for future growth. Its forward P/E is more moderate at 112.1. Astera Labs exhibits a high beta of 3.963, suggesting significant volatility compared to the broader market. The stock’s 52-week price range spans from $85.85 to $499.48, with a 50-day moving average of $288.5 and a 200-day moving average of $192.5.
Recent Earnings
Astera Labs reported revenue of approximately $1 billion, with a robust growth rate of 93.4%. The company achieved a net margin of 26.7% and a return on equity of 21.1%. Earnings per share stood at $1.46. The next earnings report is scheduled for August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Astera Labs, Inc.
In June, several insiders at Astera Labs engaged in notable stock transactions. Bethany Mayer sold 686 shares at an average price of $395.04 in a planned sale on June 24. Earlier in the month, on June 4, Jack Lazar sold 10,000 shares at $355.17 per share in a planned transaction. On the same day, Craig Barratt, Michael Hurlston, and Bethany Mayer each acquired 837 shares, though the transactions were not planned.
Analysts Set New Price Targets
On June 29, UBS maintained its hold rating on Astera Labs with a price target of $400. Stifel reaffirmed its buy rating on June 24, setting a target of $460. B of A Securities also maintained a hold rating with a $450 target on June 23. The consensus among analysts is a buy recommendation, with an average target price of $272.47 based on 22 opinions.
About Astera Labs
Astera Labs, Inc. is a technology company based in San Jose, California, specializing in semiconductor-based connectivity solutions for cloud and AI infrastructure. Founded in 2017, it designs and manufactures products that integrate microcontrollers and sensors, offering a range of connectivity solutions like PCIe/CXL retimers and smart cable modules. The company serves major customers in the hyperscale and OEM sectors.
Bottom Line
Voya Investment Management's decision to cut its stake in Astera Labs highlights the dynamic nature of institutional investing. Investors keep a close eye on such 13F filings to gauge fund managers' confidence in a stock. While this filing shows past actions, it might not reflect current positions. Astera Labs remains a significant player in the semiconductor industry, with strong financials and active insider and analyst activity.
Source: Voya Investment Management's 13F filing on $ALAB (May 12, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Voya Investment Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
